Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Blauvelt

Laboratory Safety of Dupilumab in Moderate‐to‐severe Atopic Dermatitis: Results From Three Phase III Trials ( LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS )

British Journal of Dermatology
DermatologyMedicine
2019English

Improvement of Atopic Dermatitis With Dupilumab Occurs Equally Well Across Different Anatomic Regions: Data From Phase 3 Clinical Trials

British Journal of Dermatology
DermatologyMedicine
2019English

Ixekizumab Treatment for Psoriasis: Integrated Efficacy Analysis of Three Double-Blinded, Controlled Studies (UNCOVER-1, UNCOVER-2, UNCOVER-3)

British Journal of Dermatology
DermatologyMedicine
2018English

Efficacy and Safety of Continuous Every 2-Week Dosing of Ixekizumab Over 52 Weeks in Patients With Moderate-To-Severe Plaque Psoriasis in a Randomized Phase 3 Trial (IXORA-P)

British Journal of Dermatology
DermatologyMedicine
2018English

伊赛珠单抗对银屑病的治疗:三项双盲对照研究的综合药效分析(发现-1、发现-2、发现-3)

British Journal of Dermatology
DermatologyMedicine
2018English

Brodalumab in Patients Who Had Inadequate Response to Ustekinumab

British Journal of Dermatology
DermatologyMedicine
2019English

605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

伊赛珠单抗在中度至重度生殖器银屑病中的疗效和安全性

British Journal of Dermatology
DermatologyMedicine
2018English

Ixekizumab Efficacy and Safety in Moderate-To-Severe Genital Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Dupilumab 临床试验中的结膜炎

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy